Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Yu‐Pei Chen, Jun Ma, Fang‐Yun Xie et al.|The Lancet|2021

Cited by 234